Three top army officers including ex-DG ISPR Asim Bajwa reshuffled

Published
27

Three army officers, including former director general (DG) of the Inter-Services Public Relations (ISPR), Lt Gen Asim Bajwa, are to be reshuffled, according to a handout released by the army's media wing on Thursday.

Lt Gen Asim Bajwa has been posted as corps commander southern command (Quetta), replacing Lt Gen Aamer Riaz, ISPR said.

Lt Gen Riaz has been appointed Corps Commander Lahore, while Lt Gen Sadiq Ali, who currently holds the position, has been posted as inspector general of the Arms Branch at General Headquarters, Rawalpindi, ISPR said.

Lt Gen Ali will replace Lt Gen Asim Bajwa, who was posted as the inspector general of the Arms Branch by Chief of Army Staff Gen Qamar Javed Bajwa.

Lt Gen Asim Bajwa remained the public face of the military for nearly four-and-a-half years, and was the first three-star general to hold the position.

He was succeeded as DG ISPR by Maj Gen Asif Ghafoor, the current ISPR chief, in Dec 2016.

Opinion

Editorial

Nuclear uncertainty
Updated 23 Oct, 2026

Nuclear uncertainty

With matters frozen in the political and diplomatic spheres, it will take military-to-military engagement to prevent miscalculation in the strategic sphere.
Auto illusion
Updated 23 Oct, 2026

Auto illusion

PAKISTAN’S draft auto policy 2026-31 is ambitious in its targets and directionless in its strategy. It promises...
Two crimes
23 Oct, 2026

Two crimes

THE senseless killing of a teenager by his employers in Multan is a crime that deserves unqualified condemnation. It...
Makkah pact clarity
Updated 22 Oct, 2026

Makkah pact clarity

Fresh aggression can kick off a firestorm that will be in no one’s control, hence it is best to abandon such reckless plans.
Common ground
Updated 22 Oct, 2026

Common ground

Regrettably, the two sides still fail to see the country’s economic, security, and governance crises as challenges that must be solved politically.
The treatment gap
22 Oct, 2026

The treatment gap

A BREAST cancer diagnosis no longer carries the bleak outlook it did a generation ago. Targeted medicines,...